News & Media

The eye exam detecting chronic health conditions

A regular eye exam can now detect early signs of chronic conditions like diabetes and heart disease due to AI technology. Groundbreaking research from the University of Auckland. Ehsan Vaghefi,…

Toku EyesSeptember 14, 2024

Business News

Toku Appoints Former Google Head of Cardiovascular Health as Chief Health Officer

SAN DIEGO--(BUSINESS WIRE)--Toku is delighted to announce the appointment of Professor Michael V. McConnell, MD, MSEE to the role of Chief Health Officer. Professor McConnell’s former roles include Director of…

Toku EyesApril 2, 2024

AI Technology Business News

Toku obtains CE and UKCA marks for AI cardiovascular risk assessments through the eye

Toku’s AI technology, CLAiR, has obtained CE and UKCA Marks. CLAiR provides fast, accurate, non-invasive cardiovascular disease (CVD) risk assessments using standard retinal images. Toku Inc announced it has obtained…

Toku EyesFebruary 5, 2024

AI Technology Business News

Toku joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation

American Heart Association consortium advances development of evidence-based health tech solutions SAN DIEGO--(BUSINESS WIRE)--Toku Inc, a provider of an AI-based screening tool for detection of cardiovascular risk through retinal imaging,…

Toku EyesOctober 31, 2023

AI Technology Business News Eye Health

Toku Eyes poised for US breakthrough after big industry names back $13m raise

Toku Eyes founder Dr Ehsan Vaghefi says his company's AI software can analyse eye images faster than a human clinician and pick up things they might miss. Auckland-based Toku Eyes seems…

Toku EyesApril 19, 2023

AI Technology Business News Eye Health

Toku Inc. Series A Preferred Investment Round Led by National Vision, Inc. and Topcon Healthcare

To commercialize Toku’s artificial intelligence platform that analyzes retinal images to detect cardiovascular disease and other potential health risks DULUTH, Ga.--(BUSINESS WIRE)--Toku Inc., a leader in applying AI-powered diagnostic and…

Toku EyesApril 17, 2023

AI Technology Business News Eye Health

42PLUS1 US Satellite Award

Happy to announce the winner of the 42PLUS1 US Satellite Award! Congratulations Toku Eyes! 🚀🚀🚀 What a great innovation you shared at the DxPx Conference stage about the artificial intelligence…

Toku EyesAugust 1, 2022

AI Technology Diabetic Screening Eye Health

On a mission to democratize eyecare, Toku Eyes takes its technology to the U.S.

The company uses AI to detect eye health, as well as diabetes and cardiovascular conditions There are 43 million people in the world who are blind, and another 295 million who have…

Toku EyesJune 1, 2022

AI Technology Diabetic Screening Eye Health

NZ-based AI firm launches tool to assess heart risk through retinal scans in U.S.

Toku Eyes, a New Zealand-based healthcare AI company, is launching its tool that assesses heart risk through a retinal scan in the U.S. The tool, called CLAiR, uses an AI…

Toku EyesJune 1, 2022

AI Technology Business News

Kiwi AI tool launches in India

An Artificial Intelligence retinal screening tool, developed in New Zealand, is being used in 20 eye clinics in India and is about to launch in the United States. THEIA has…

Toku EyesMay 26, 2022

Diabetic Screening Eye Health

New Zealand tech company develops tool to detect diseases like diabetes

Around 280,000 New Zealanders have diabetes, with the disease almost three times more common in Māori than non-Māori. And mortality rates for the disease are nine times higher for Māori…

Toku EyesMay 10, 2022

AI Technology Eye Health

An easier way to detect diabetes through technology

Detecting diabetes is about to get a whole lot easier. A Kiwi company has created a revolutionary technology called THEIA, which uses AI to examine blood vessels in the eye…

Toku EyesMay 3, 2022

AI Technology Clinical Trials Eye Health

AI tool detects early signs of eye disease

The trial of an Artificial Intelligence retinal screening tool, developed in New Zealand, showed it did not miss any referable disease for diabetic patients at risk of eye disorders. THEIA…

Toku EyesJuly 25, 2021

Business News

Advice from a clear-sighted entrepreneur

Ehsan Vaghefi has been a guide all his life. After all, when other children his age were being helped across the street by their parents, he was helping his blind…

Toku EyesJuly 19, 2021

Business News

A New Zealand startup using AI to detect eye disease raises $3.35 million

New Zealand startup Toku Eyes, which has built an artificial intelligence platform to improve early detection of eye diseases such as macular degeneration, glaucoma and other diseases observable via the…

Toku EyesJune 29, 2021

Clinical Trials

Top scores for Kiwi AI screening tool

Toku Eyes has completed its first prospective clinical trial of its artificial intelligence (AI) screening platform Theia, designed to support more cost-effective diagnosis and prognosis of eye disorders. The trial,…

Toku EyesJune 29, 2021

Clinical Trials

Toku Eyes raises millions for AI Tech that helps stop diabetes, preventable blindness

Auckland startup Toku Eyes has raised $3.6 million to develop its AI software - which founder Associate Professor Ehsan Vaghefi says can analyse eye images faster than a human clinician…

Toku EyesJune 28, 2021

AI Technology Business News Diabetic Screening

A multi-center prospective evaluation of THEIA

A multi-center prospective evaluation of THEIA to detect diabetic retinopathy (DR) and diabetic macular edema (DME) in the New Zealand screening program Purpose: to assess the efficacy of THEIA, an…

Toku EyesJune 23, 2021

Ask us about your health screening requirements